Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Differential expression of coagulation and inflammation genes in ITP patients before and after treatment with thrombopoietin receptor agonists

View Full Paper
Ask AI
Bookmark
Share

Authors

LGLamya GarabetAEAnna Eriksson

Discussion

Loading...

Member takes

Overview

Analysis reveals changes in inflammation and coagulation genes in ITP patients after thrombopoietin receptor agonist treatment, implying a complex risk of thrombotic events.

Key Points

  • This research aims to explore the differential expression of coagulation and inflammation genes in ITP patients undergoing treatment with TPO-RA.
  • Global gene expression profiling conducted in ITP patients and healthy controls
  • Analyzed expression of 60 coagulation and inflammation genes pre- and post-TPO-RA treatment
  • Used Clariom™ D microarrays to assess gene expression
  • Temporal patterns visualized with self-organizing maps
  • Differential expression analysis conducted using limma un-paired t-test.
  • 10 genes significantly upregulated and 15 downregulated in ITP patients before TPO-RA treatment
  • Post-treatment analysis showed various genes shifting between upregulated and downregulated states
  • Overall findings suggest a shift towards enhanced immune tolerance and increased platelet counts, but also a procoagulant state.

Cite This Study

Garabet et al. (2025) studied this question.

synapsesocial.com/papers/69362f694fa91c937236df1dhttps://doi.org/10.1182/blood-2025-3018
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Single-cell transcriptome deciphers key targets of thrombopoietin receptor agonists and immune microenvironment characteristics of immune thrombocytopenia2026 · 2 citations
  2. 2Transcriptomic characterization of platelets in immune thrombocytopenia indicates sustained activation and mitochondrial dysfunction2025
  3. 3Metabolic reprogramming of megakaryocyte subpopulations in ITP: Implications for TSPO in predicting response to TPO-RA2025 · 1 citations
  4. 4Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia2024 · 1 citations
  5. 5Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes2025